neurotechnology

Market Access

The field of neurotechnology is rapidly evolving, bringing together advances in neuroscience, engineering, materials science, and computing.

Views & Analysis

Advanced implantable medical devices could treat hundreds of chronic conditions in the future.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.